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Over 100 disease-gene associations have been identified
by whole-exome sequencing since the first reports in
2010, leading to a revolution in rare disease-gene dis-
covery [1,2]. However, many cases remain unsolved due
to the fact that ~100-1000 loss of function, candidate
variants remain after removing those deemed as com-
mon, low quality or non-pathogenic. In some cases it
may be possible to use multiple affected individuals,
linkage data, identity-by-descent inference, identification
of de novo heterozygous mutations from trio analysis, or
prior knowledge of affected pathways to narrow down
to the causative variant [3]. Where this is not possible
or successful, one approach is to use phenotype data to
evaluate whether a particular candidate variant is likely
to result in the patient’s clinical manifestations.
Model organism phenotype data represents a highly
pertinent but under-utilised resource for such disease
gene discovery. Whilst some 1800 human genes were
associated with human phenotype ontology annotations
(HPO) at the time of publication, a further 5700 genes
have been shown to have phenotype data available from
mouse and zebrafish model organism databases [4]. We
have previously developed algorithmic approaches to
semantically compare disease phenotypes with mouse
and zebrafish phenotypes for disease candidate gene
identification [5-8].
We have previously reported that comparisons to
mouse phenotype data can dramatically increase the
performance of exome analysis prioritization [9]. In the
work presented here we combine the comparison of
patient phenotypes to known disease as well as mouse
and zebrafish phenotypes for each candidate variant in the
exome. Where phenotype data is not available for a candi-
date we use proximity in protein-protein networks to
genes with phenotype data to inform on candidacy based
on guilt-by-association. The output is combined with mea-
sures of variant candidacy such as pathogenicity and allele
frequency and synergistically improves performance: the
causative variant is identified as the top hit in up to 96% of
exomes for known associations and 49% of exomes for
previously undescribed associations.
Our software, Exomiser, is openly available to use at
our website [http://www.sanger.ac.uk/resources/databases/
exomiser/query] and for download to perform local ana-
lysis. We are currently collaborating with the NIH
Undiagnosed Disease Program to achieve diagnosis of
problematic cases through exome analysis. In conclu-
sion, our results clearly show the value of collecting
comprehensive clinical phenotype data for translational
bioinformatics and future work will focus on producing
a robust solution for clinical diagnostics.
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